AbbieVie Suffers a Second Verdict Against AndroGel®
$140 Million Verdict Against AbbieVie in “Low T” Trial Jurors returned a $140 million verdict for the plaintiff in the latest testosterone (“Low T”) trial against manufacturer, AbbVie in October of ...
Read More
